If you’re an adult with OCD and your symptoms are interfering with your ability to function, you may qualify to participate in an ongoing research study involving an investigational medication.
Adults diagnosed with obsessive compulsive disorder (OCD) and receiving SSRI treatment with unsatisfactory response could meet criteria for the new study with Okanagan Clinical Trials.
“OCD is a serious condition that causes significant distress for those it affects,” said Dr. Paul Latimer, psychiatrist and principal investigator with Okanagan Clinical Trials. “Treatment focuses on eliminating anxiety-causing obsessions and compulsive behaviour so that daily activities can be carried out without interruption.”
OCD is a serious mental illness affecting roughly two per cent of the population. It is characterized by obsessive thoughts that cause anxiety and repetitive compulsive behaviours such as excessive washing or checking that temporarily relieve anxiety. A vicious circle results which is distressing to the individual and can be very time consuming.
To participate in the new study currently underway at Okanagan Clinical Trials, volunteers should be between the ages of 19 and 65, diagnosed with obsessive compulsive disorder and being treated with an SSRI medication for at least two months with insufficient results.
This is an international study to gather information from 99 patients. Okanagan Clinical Trials was selected to participate because of its proven track record in conducting clinical trials since 1992.
Effects will be measured for 12 weeks. Participation in the study will not affect regular or extended medical coverage and participants may be compensated for their time and travel. As always, volunteers are free to leave the study at any time.
Okanagan Clinical Trials can be reached at 250-862-8141.